Podcast
Questions and Answers
What is the primary advantage of using nonoral estrogens?
What is the primary advantage of using nonoral estrogens?
- They have a higher risk of deep vein thrombosis
- They avoid first pass metabolism and result in a more physiologic estradiol : estrone ratio (correct)
- They are more effective in treating urogenital atrophy
- They are only available in transdermal dosage forms
What is the main component of conjugated equine estrogens?
What is the main component of conjugated equine estrogens?
- Ethinyl estradiol
- 17α-dihydroequilin
- Estrone sulfate (correct)
- Estradiol
What is the effect of oral estradiol on estrone concentrations?
What is the effect of oral estradiol on estrone concentrations?
- It increases estrone concentrations three to six times (correct)
- It reduces estrone concentrations to half
- It completely eliminates estrone
- It has no effect on estrone concentrations
What is the result of using transdermal estrogen dosage forms?
What is the result of using transdermal estrogen dosage forms?
What is the indication for Femring?
What is the indication for Femring?
What is the trend in recent evidence regarding estrogen doses?
What is the trend in recent evidence regarding estrogen doses?
What is a common adverse effect of estrogen therapy?
What is a common adverse effect of estrogen therapy?
Which type of estrogen therapy is less likely to cause breast tenderness and gallbladder disease?
Which type of estrogen therapy is less likely to cause breast tenderness and gallbladder disease?
What is a contraindication for MHT?
What is a contraindication for MHT?
What is the increased risk associated with combined oral MHT containing estrogen and progestogen?
What is the increased risk associated with combined oral MHT containing estrogen and progestogen?
What is the effect of estrogen alone on endometrial cancer risk in individuals with an intact uterus?
What is the effect of estrogen alone on endometrial cancer risk in individuals with an intact uterus?
What is the effect of combined estrogen and progestogen therapy on dementia in postmenopausal individuals 65 years or older?
What is the effect of combined estrogen and progestogen therapy on dementia in postmenopausal individuals 65 years or older?
